RG7287
RG7287 is an activating antibody inhibitor targeting human CDCP1. RG7287 prevents the loss of contact inhibition caused by the co-transformation of NIH3T3 cells with CDCP1 and Src in focus formation assays. RG7287 inhibits tumor cell proliferation and leads to a significant reduction in CDCP1 levels[1].
Product Specifications
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.666
Smiles
[RG7287]
Precautions
H302, H315, H319, H335
References & Citations
[1]Gwendlyn Kollmorgen, et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol. 2013 Dec;7 (6) :1142-51.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
272294 220 Roll (220 Marker (s) x 1 Roll)
PMF-EAUFLUVIALE-GR4-RLL090 Pipe Markers for Water
Sign In for Pricing
View Details 
MBS2116036-01 0.1 mL
HRP-Linked Polyclonal Antibody to Interleukin 8 Receptor Beta (IL8Rb)
Sign In for Pricing
View Details MBS2116036-02 0.2 mL
HRP-Linked Polyclonal Antibody to Interleukin 8 Receptor Beta (IL8Rb)
Sign In for Pricing
View Details MBS2116036-03 0.5 mL
HRP-Linked Polyclonal Antibody to Interleukin 8 Receptor Beta (IL8Rb)
Sign In for Pricing
View Details